Posts

Dermatomyositis Treatment Market Segments, Leading Player, Application and Forecast Analysis - BioSpace

Albany NY, United States: Dermatomyositis is a form of inflammatory myopathy in which degenerative and inflammatory changes occur in the skin and the muscles. It is a rare form of acquired muscle disease that is accompanied by skin rashes. Symptoms of dermatomyositis may vary broadly from patient to patient. Deformities in the muscles may initiate with weakness and pain in the muscles of the thighs (proximal muscles), the hips, the upper arms, and the trunk. The muscles may become tender, sore, and stiff and eventually, they may express signs of degeneration (atrophy). Persons affected by dermatomyositis may experience struggle in the execution of certain tasks such as swallowing, or/and speaking, or/and climbing stairs, or/and raising their arms. Deformities in the skin often comprise typical, reddish-purple-colored, heliotrope rashes across the cheeks or on the upper portion of the eyelid (heliotrope eyelids), on the scalp and parts of the forehead, and on bridge of the nose, showin...

Cost and Cephalexin: How to Find Savings, Lower Costs, and More - Healthline

Image
If you have a bacterial infection, your doctor may suggest treatment with cephalexin (Keflex). Cephalexin is a generic prescription drug that's used to treat infections caused by certain types of bacteria. It's used in adults and children ages 1 year and above. It's also available as the brand-name drug Keflex. Examples of infections that cephalexin is used to treat include: This drug comes as capsules, tablets, and an oral suspension. All forms of cephalexin are taken by mouth. Cephalexin belongs to a group of drugs called cephalosporin antibiotics. Keep reading for details on cephalexin and cost as well as information on how to save money on prescriptions. Note: For more details on cephalexin, see this in-depth article. The price you pay for cephalexin can vary. Your cost may depend on your treatment plan, your insurance coverage, and the pharmacy you use. It can also depend on the form and strength of cephalexin your doctor prescribes. To find out how much you'll pa...

What Is Melasma? Dark Patches on Face, Explained By Derms - Health.com

Image
You probably noticed it in the mirror one day while doing your daily skincare routine or inspecting that rogue pimple that popped up out of nowhere: a blotch (or a few), just a shade or two darker from your actual skin color. That, friends, is what's known as melasma—and you're not alone if you've noticed it on your face. According to the American Academy of Dermatology (AAD), women are most likely to experience melasma (only about 10% of people who have melasma are men), and while it can affect anyone, people with darker skin have a greater chance of seeing the blotches. But there's good news: Though it can be difficult to treat (more on that later), melasma isn't dangerous from a health perspective. The patches can still cause a bit of alarm in those who've never seen them before though, so we tapped dermatologists to give us the lowdown on melasma—including what you can do to make it go away (if that's what you want!), and whether you can ...

Is COVID Tongue a Real Symptom? - Integris

Image
20 May 2022 First it was a loss of smell and taste, then it was COVID toes, then it was delirium and hallucinations. Altogether, these unusual symptoms of COVID-19 were a part of a growing list that seemed to change on a weekly basis with patients experiencing new and undiagnosed problems.   Can we add COVID tongue to that list, too? Some people with COVID have been experiencing changes to their tongue, such as inflammation and swelling, and have turned to the internet for answers. But are these complications coincidental or is there any evidence to tie it specifically to the coronavirus? This blog will help address those questions.  What is COVID tongue? There doesn't seem to be any debate on if a minority of COVID patients are experiencing symptoms related to their mouth and tongue. The bigger question is i...

Anti-parasitic drug prevents bacterial complications of scabies on mass scale - Medical Xpress

Image
The Lancet Regional Health - Western Pacific (2022). DOI: 10.1016/j.lanwpc.2022.100433"> The Lancet Regional Health - Western Pacific (2022). DOI: 10.1016/j.lanwpc.2022.100433" width="678" height="530"> The Northern Division of Fiji with scabies prevalence survey sites indicated (inset map shows location of Fiji and the Northern Division in the Pacific region). Credit: The Lancet Regional Health - Western Pacific (2022). DOI: 10.1016/j.lanwpc.2022.100433 An anti-parasitic drug, delivered on a mass scale, can prevent potentially dangerous bacterial complications of scabies in Fiji, according to a new study. The research led by the Murdoch Children's Research Institute (MCRI), the Kirby Institute at UNSW Sydney and the Ministry of...

Exploring the impact of bacterial infection and gut microbiome on colorectal cancer development - News-Medical.Net

Image
Intestinal micro-biodiversity is important for maintaining colorectal and general health. Imbalance in this microenvironment can result in chronic infections, even cancer. Development of colorectal cancer (CRC) has been alluded to abnormal gut-bacterial activity and infections. However, the complexity of the intestinal microbiome makes it challenging to identify which bacterial types promote CRC pathogenesis in what way. A review-; which was made available online on 27 th January 2022, and published in Volume 135, issue 4 of Chinese Medical Journal on 20 th February 2022-; investigates this using chronic Salmonella infections as an example. Dr. Jun Sun, author, and Professor at the University of Illinois at Chicago, explains the study's rationale. "Better understanding of the enteric microbiome and pathogens could lead to new approaches for preventing and treating CRC, by inhibiting chronic infection and inflammation." Pathogenic bacteria attack host physiolog...

Gentamicin-Eluting Bone Graft Substitute Gets FDA Clearance - Monthly Prescribing Reference

Image
The Food and Drug Administration (FDA) has cleared Cerament G for use as a bone void filler in skeletally mature patients as an adjunct to systemic antibiotic therapy and surgical debridement as part of the surgical treatment of osteomyelitis. Cerament G is a resorbable, gentamicin-eluting ceramic bone graft substitute consisting of hydroxyapatite, α-calcium sulfate hemihydrate, and the aminoglycoside antibiotic gentamicin sulfate. The combination allows for natural bone healing, while reducing the recurrence of chronic osteomyelitis from gentamicin-sensitive microorganisms. Cerament G resorbs and is replaced by bone during the healing process; the cured paste acts as a temporary support media. "The benefits of Cerament G for patients and clinics, have been validated in several very strong clinical trials, and have paved the way for our strong sales in Europe, where Cerament G accounts for a clear majority of our sales," said Emil Billbäck, CEO of BONES...